≥99% HPLCIntranasal spray

BPC Spray

Name: BPC Spray
Brand: Dripfy
Availability: InStock

What it is?

BPC Spray is a topical delivery format of BPC-157 designed for localised application. It is positioned for protocols where convenience, targeted exposure, and non-injectable delivery are preferred, while maintaining a recovery-focused signalling profile.

Dripfy Advantage

Localised delivery strategy: Supports targeted application to specific areas, aligning with protocols where local outcomes are monitored.
Non-injectable compliance: Designed for users and settings where injectable administration is not optimal, improving routine adherence.
Barrier and repair signalling: Positioned for tissue repair pathways relevant to wound recovery and inflammation balance in topical protocols.
Convenience for consistent use: Spray format supports frequent, structured application, often critical for local recovery routines.

Clinical Applications & Therapeutic Potential

Local injury support: Potential support for localised discomfort and inflammation-associated markers in minor injury contexts.
Wound healing pathways: Positioned for skin and surface-level repair signalling and recovery endpoints.
Inflammation modulation: Potential reductions in local inflammatory response markers with improved recovery comfort.
Injection-avoidant protocols: A practical option where non-invasive delivery is a requirement for the protocol design.

Composition & Formulation

Active peptide: BPC-157 (synthetic pentadecapeptide)
Formulation: Intranasal spray (aqueous buffered solution; preservative-controlled)

€496

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Intranasal spray
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

BPC Spray

Investigational topical BPC-157 (regenerative / cytoprotective), spray format · Intranasal spray

D· Preliminary evidence

BPC Spray delivers the BPC-157 peptide in a topical, non-injectable format intended for localised application. The proposed repair and inflammation-balancing signalling is the same as for BPC-157, but how much peptide is absorbed through skin or mucosa and whether the effect is local or systemic is poorly characterised in humans. It should be regarded as investigational rather than an established topical treatment.

Studied use areas

Localised tissue-repair support (research context)
Non-injectable recovery routines where topical use is preferred
Inflammation balance around a treated area (studied)
Convenience-oriented, repeat topical application

Safety & status

Investigational and not an approved medicine; topical human data are essentially absent
Absorption and local-versus-systemic exposure are uncertain
Prohibited in competitive sport under the WADA non-approved-substance category
Use only under qualified physician oversight

⚕ Clinical note: This card is educational and is not medical advice. BPC Spray is an investigational topical form of BPC-157; any use must be individualised and supervised by the treating physician.

Evidence: Investigational — animal-derived rationale, topical human data essentially absent · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings